Oxidised low density lipoprotein (oxLDL) contributes to atherosclerosis
. Lipid oxidation products including oxidised phosphatidylcholine
(oxPC), oxidised cholesteryl ester (oxCE) and
lyso-phosphatidylcholine (LPC) which is produced by the action of
phospholipases on oxPC, have been detected and characterised in oxLDL
, plasma and atherosclerotic lesions. These oxidation products
may represent bioactive lipids with potential pro-inflammatory capacity
that affect plaque progression and stability .